Product
Sinovac PCV24
1 clinical trial
1 indication
Indication
Pneumococcal Infectious DiseaseClinical trial
A Randomized, Double-blind, Controlled Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 24-valent Pneumococcal Conjugate Vaccine in Adults 18 Years of Age and OlderStatus: Not yet recruiting, Estimated PCD: 2024-12-20